Literature DB >> 22068586

Molecular and cellular characteristics of ABCA3 mutations associated with diffuse parenchymal lung diseases in children.

Florence Flamein1, Laure Riffault, Céline Muselet-Charlier, Julie Pernelle, Delphine Feldmann, Laurence Jonard, Anne-Marie Durand-Schneider, Aurore Coulomb, Michèle Maurice, Lawrence M Nogee, Nobuya Inagaki, Serge Amselem, Jean Christophe Dubus, Virginie Rigourd, François Brémont, Christophe Marguet, Jacques Brouard, Jacques de Blic, Annick Clement, Ralph Epaud, Loïc Guillot.   

Abstract

ABCA3 (ATP-binding cassette subfamily A, member 3) is expressed in the lamellar bodies of alveolar type II cells and is crucial to pulmonary surfactant storage and homeostasis. ABCA3 gene mutations have been associated with neonatal respiratory distress (NRD) and pediatric interstitial lung disease (ILD). The objective of this study was to look for ABCA3 gene mutations in patients with severe NRD and/or ILD. The 30 ABCA3 coding exons were screened in 47 patients with severe NRD and/or ILD. ABCA3 mutations were identified in 10 out of 47 patients, including 2 homozygous, 5 compound heterozygous and 3 heterozygous patients. SP-B and SP-C expression patterns varied across patients. Among patients with ABCA3 mutations, five died shortly after birth and five developed ILD (including one without NRD). Functional studies of p.D253H and p.T1173R mutations revealed that p.D253H and p.T1173R induced abnormal lamellar bodies. Additionally, p.T1173R increased IL-8 secretion in vitro. In conclusion, we identified new ABCA3 mutations in patients with life-threatening NRD and/or ILD. Two mutations associated with ILD acted via different pathophysiological mechanisms despite similar clinical phenotypes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22068586      PMCID: PMC3263986          DOI: 10.1093/hmg/ddr508

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  35 in total

1.  Characterization and classification of ATP-binding cassette transporter ABCA3 mutants in fatal surfactant deficiency.

Authors:  Yoshihiro Matsumura; Nobuhiro Ban; Kazumitsu Ueda; Nobuya Inagaki
Journal:  J Biol Chem       Date:  2006-09-07       Impact factor: 5.157

2.  Alteration of the pulmonary surfactant system in full-term infants with hereditary ABCA3 deficiency.

Authors:  Frank Brasch; Sven Schimanski; Christian Mühlfeld; Stefan Barlage; Thomas Langmann; Charalampos Aslanidis; Alfred Boettcher; Ashraf Dada; Horst Schroten; Eva Mildenberger; Eric Prueter; Manfred Ballmann; Matthias Ochs; Georg Johnen; Matthias Griese; Gerd Schmitz
Journal:  Am J Respir Crit Care Med       Date:  2006-05-25       Impact factor: 21.405

3.  Functional and trafficking defects in ATP binding cassette A3 mutants associated with respiratory distress syndrome.

Authors:  Naeun Cheong; Muniswamy Madesh; Linda W Gonzales; Ming Zhao; Kevin Yu; Philip L Ballard; Henry Shuman
Journal:  J Biol Chem       Date:  2006-01-16       Impact factor: 5.157

Review 4.  Inherited surfactant protein-B deficiency and surfactant protein-C associated disease: clinical features and evaluation.

Authors:  Aaron Hamvas
Journal:  Semin Perinatol       Date:  2006-12       Impact factor: 3.300

5.  Expression of ABCA3 in developing lung and other tissues.

Authors:  Mildred T Stahlman; Valérie Besnard; Susan E Wert; Timothy E Weaver; Sharon Dingle; Yan Xu; Kara von Zychlin; Sandra J Olson; Jeffrey A Whitsett
Journal:  J Histochem Cytochem       Date:  2006-09-18       Impact factor: 2.479

6.  Ultrastructure of lamellar bodies in congenital surfactant deficiency.

Authors:  V Edwards; E Cutz; S Viero; A M Moore; L Nogee
Journal:  Ultrastruct Pathol       Date:  2005 Nov-Dec       Impact factor: 1.094

Review 7.  Genetic disorders of surfactant homeostasis.

Authors:  Jeffrey A Whitsett; Susan E Wert; Yan Xu
Journal:  Biol Neonate       Date:  2005-06-01

8.  Unexplained neonatal respiratory distress due to congenital surfactant deficiency.

Authors:  Marco Somaschini; Lawrence M Nogee; Isabella Sassi; Olivier Danhaive; Silvia Presi; Renata Boldrini; Cristina Montrasio; Maurizio Ferrari; Susan E Wert; Paola Carrera
Journal:  J Pediatr       Date:  2007-06       Impact factor: 4.406

9.  Enhanced IL-1beta-induced IL-8 production in cystic fibrosis lung epithelial cells is dependent of both mitogen-activated protein kinases and NF-kappaB signaling.

Authors:  Céline Muselet-Charlier; Telma Roque; Emilie Boncoeur; Katarina Chadelat; Annick Clement; Jacky Jacquot; Olivier Tabary
Journal:  Biochem Biophys Res Commun       Date:  2007-04-02       Impact factor: 3.575

10.  A role for MCP-1/CCR2 in interstitial lung disease in children.

Authors:  Dominik Hartl; Matthias Griese; Thomas Nicolai; Gernot Zissel; Christine Prell; Dietrich Reinhardt; Dolores J Schendel; Susanne Krauss-Etschmann
Journal:  Respir Res       Date:  2005-08-11
View more
  27 in total

1.  Disruption of N-linked glycosylation promotes proteasomal degradation of the human ATP-binding cassette transporter ABCA3.

Authors:  Michael F Beers; Ming Zhao; Yaniv Tomer; Scott J Russo; Peggy Zhang; Linda W Gonzales; Susan H Guttentag; Surafel Mulugeta
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-10-18       Impact factor: 5.464

Review 2.  Interstitial lung disease in children.

Authors:  Christin S Kuo; Lisa R Young
Journal:  Curr Opin Pediatr       Date:  2014-06       Impact factor: 2.856

3.  Increased Risk of Interstitial Lung Disease in Children with a Single R288K Variant of ABCA3.

Authors:  Thomas Wittmann; Sabrina Frixel; Stefanie Höppner; Ulrike Schindlbeck; Andrea Schams; Matthias Kappler; Jan Hegermann; Christoph Wrede; Gerhard Liebisch; Anne Vierzig; Angela Zacharasiewicz; Matthias Volkmar Kopp; Christian F Poets; Winfried Baden; Dominik Hartl; Anton H van Kaam; Peter Lohse; Charalampos Aslanidis; Ralf Zarbock; Matthias Griese
Journal:  Mol Med       Date:  2016-02-26       Impact factor: 6.354

Review 4.  Diseases of pulmonary surfactant homeostasis.

Authors:  Jeffrey A Whitsett; Susan E Wert; Timothy E Weaver
Journal:  Annu Rev Pathol       Date:  2015       Impact factor: 23.472

5.  Surfactant proteins in pediatric interstitial lung disease.

Authors:  Matthias Griese; Elke Lorenz; Meike Hengst; Andrea Schams; Traudl Wesselak; Daniela Rauch; Thomas Wittmann; Valerie Kirchberger; Amparo Escribano; Thomas Schaible; Winfried Baden; Johannes Schulze; Heiko Krude; Charalampos Aslanidis; Nicolaus Schwerk; Matthias Kappler; Dominik Hartl; Peter Lohse; Ralf Zarbock
Journal:  Pediatr Res       Date:  2015-09-16       Impact factor: 3.756

Review 6.  An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy.

Authors:  Geoffrey Kurland; Robin R Deterding; James S Hagood; Lisa R Young; Alan S Brody; Robert G Castile; Sharon Dell; Leland L Fan; Aaron Hamvas; Bettina C Hilman; Claire Langston; Lawrence M Nogee; Gregory J Redding
Journal:  Am J Respir Crit Care Med       Date:  2013-08-01       Impact factor: 21.405

7.  Respiratory failure in a term newborn due to compound heterozygous ABCA3 mutation: the case report of another lethal variant.

Authors:  J Malý; M Navrátilová; H Hornychová; A C Looman
Journal:  J Perinatol       Date:  2014-12       Impact factor: 2.521

8.  Interstitial lung disease in two brothers with novel compound heterozygous ABCA3 mutations.

Authors:  Hiroshi Kitazawa; Kunihiko Moriya; Hidetaka Niizuma; Kengo Kawano; Yuka Saito-Nanjo; Toru Uchiyama; Takeshi Rikiishi; Yoji Sasahara; Osamu Sakamoto; Yasuhiro Setoguchi; Shigeo Kure
Journal:  Eur J Pediatr       Date:  2013-02-27       Impact factor: 3.183

9.  Functional characterization of four ATP-binding cassette transporter A3 gene (ABCA3) variants.

Authors:  June Y Hu; Ping Yang; Daniel J Wegner; Hillary B Heins; Cliff J Luke; Fuhai Li; Frances V White; Gary A Silverman; F Sessions Cole; Jennifer A Wambach
Journal:  Hum Mutat       Date:  2020-04-01       Impact factor: 4.878

10.  Functional Genomics of ABCA3 Variants.

Authors:  Jennifer A Wambach; Ping Yang; Daniel J Wegner; Hillary B Heins; Cliff Luke; Fuhai Li; Frances V White; F Sessions Cole
Journal:  Am J Respir Cell Mol Biol       Date:  2020-10       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.